Phathom Pharmaceuticals Statistics
Total Valuation
PHAT has a market cap or net worth of $1.01 billion. The enterprise value is $1.46 billion.
Important Dates
The last earnings date was Thursday, October 30, 2025, before market open.
| Earnings Date | Oct 30, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
PHAT has 69.65 million shares outstanding. The number of shares has increased by 20.89% in one year.
| Current Share Class | 69.65M |
| Shares Outstanding | 69.65M |
| Shares Change (YoY) | +20.89% |
| Shares Change (QoQ) | +1.28% |
| Owned by Insiders (%) | 4.00% |
| Owned by Institutions (%) | 45.83% |
| Float | 49.29M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 7.15 |
| Forward PS | 3.74 |
| PB Ratio | n/a |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 9.93 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 2.23
| Current Ratio | 2.23 |
| Quick Ratio | 2.05 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -3.04 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | -42.54% |
| Return on Invested Capital (ROIC) | -54.18% |
| Return on Capital Employed (ROCE) | -145.06% |
| Revenue Per Employee | $344,707 |
| Profits Per Employee | -$642,974 |
| Employee Count | 427 |
| Asset Turnover | 0.47 |
| Inventory Turnover | 5.58 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +49.33% in the last 52 weeks. The beta is 0.45, so PHAT's price volatility has been lower than the market average.
| Beta (5Y) | 0.45 |
| 52-Week Price Change | +49.33% |
| 50-Day Moving Average | 12.66 |
| 200-Day Moving Average | 8.35 |
| Relative Strength Index (RSI) | 63.69 |
| Average Volume (20 Days) | 977,764 |
Short Selling Information
The latest short interest is 13.57 million, so 19.48% of the outstanding shares have been sold short.
| Short Interest | 13.57M |
| Short Previous Month | 14.13M |
| Short % of Shares Out | 19.48% |
| Short % of Float | 27.52% |
| Short Ratio (days to cover) | 10.50 |
Income Statement
In the last 12 months, PHAT had revenue of $147.19 million and -$274.55 million in losses. Loss per share was -$3.80.
| Revenue | 147.19M |
| Gross Profit | 128.42M |
| Operating Income | -213.48M |
| Pretax Income | -274.55M |
| Net Income | -274.55M |
| EBITDA | -212.78M |
| EBIT | -213.48M |
| Loss Per Share | -$3.80 |
Full Income StatementBalance Sheet
The company has $135.16 million in cash and $583.14 million in debt, giving a net cash position of -$447.98 million or -$6.43 per share.
| Cash & Cash Equivalents | 135.16M |
| Total Debt | 583.14M |
| Net Cash | -447.98M |
| Net Cash Per Share | -$6.43 |
| Equity (Book Value) | -422.53M |
| Book Value Per Share | -5.95 |
| Working Capital | 114.66M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -$225.23 million and capital expenditures -$147,000, giving a free cash flow of -$225.38 million.
| Operating Cash Flow | -225.23M |
| Capital Expenditures | -147,000 |
| Free Cash Flow | -225.38M |
| FCF Per Share | -$3.24 |
Full Cash Flow StatementMargins
Gross margin is 87.25%, with operating and profit margins of -145.03% and -186.53%.
| Gross Margin | 87.25% |
| Operating Margin | -145.03% |
| Pretax Margin | -186.53% |
| Profit Margin | -186.53% |
| EBITDA Margin | -144.56% |
| EBIT Margin | -145.03% |
| FCF Margin | n/a |
Dividends & Yields
PHAT does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -20.89% |
| Shareholder Yield | -20.89% |
| Earnings Yield | -27.07% |
| FCF Yield | -22.22% |
Analyst Forecast
The average price target for PHAT is $17.60, which is 20.88% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $17.60 |
| Price Target Difference | 20.88% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 5 |
| Revenue Growth Forecast (5Y) | 73.67% |
| EPS Growth Forecast (5Y) | n/a |
Stock ForecastsFair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
PHAT has an Altman Z-Score of -9.73 and a Piotroski F-Score of 3. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -9.73 |
| Piotroski F-Score | 3 |
